about
Cytotoxicity of Nanoparticles Contained in Food on Intestinal Cells and the Gut MicrobiotaGenetically-encoded tools for cAMP probing and modulation in living systemsMultiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiencyStrategies on the nuclear-targeted delivery of genesA holistic approach to targeting disease with polymeric nanoparticlesNovel formulations for antimicrobial peptidesCurrent Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.Can nanomedicines kill cancer stem cells?Endocytosis and Endosomal Trafficking of DNA After Gene Electrotransfer In Vitro.Hyperthermia using nanoparticles--Promises and pitfalls.Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicityCell type-specific response to high intracellular loading of polyacrylic acid-coated magnetic nanoparticlesSimple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapyCurcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's diseaseCodelivery of chemotherapeutics via crosslinked multilamellar liposomal vesicles to overcome multidrug resistance in tumorAbraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gpTumor Microenvironment Modulation via Gold Nanoparticles Targeting Malicious Exosomes: Implications for Cancer Diagnostics and TherapyRational engineering of physicochemical properties of nanomaterials for biomedical applications with nanotoxicological perspectivesMarked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibitionMetallofullerenol Gd@C₈₂(OH)₂₂ distracts the proline-rich-motif from putative binding on the SH3 domain.Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism.Conjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivoNanoparticle clearance is governed by Th1/Th2 immunity and strain background.Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity.Nanoparticles based on star polymers as theranostic vectors: endosomal-triggered drug release combined with MRI sensitivity.Pooling and Analysis of Published in Vitro Data: A Proof of Concept Study for the Grouping of Nanoparticles.Endocytosis and intracellular trafficking properties of transferrin-conjugated block copolypeptide vesicles.The emergence of multiple particle tracking in intracellular trafficking of nanomedicines.Biocompatibility of chitosan carriers with application in drug delivery.A preliminary study on the interaction between Asn-Gly-Arg (NGR)-modified multifunctional nanoparticles and vascular epithelial cellsUnderstanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdlesEffects of ligand distribution on receptor-diffusion-mediated cellular uptake of nanoparticles.Surface functionality of nanoparticles determines cellular uptake mechanisms in mammalian cells.Biomechanics and thermodynamics of nanoparticle interactions with plasma and endosomal membrane lipids in cellular uptake and endosomal escape.Elucidating the role of free polycationic chains in polycation gene carriers by free chains of polyethylenimine or N,N,N-trimethyl chitosan plus a certain polyplex.An amino acid-based amphoteric liposomal delivery system for systemic administration of siRNA.The impact of receptor recycling on the exocytosis of αvβ3 integrin targeted gold nanoparticles.A PEG-Fmoc conjugate as a nanocarrier for paclitaxelThe co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression.Encapsulation in nanoparticles improves anti-cancer efficacy of carboplatin.
P2860
Q26750622-B29F89E7-68E8-49CC-AA4A-2888E1598A27Q26781567-E7BBFCF3-2754-4A64-9A10-055850D9BE2FQ26827999-DD5A0DDD-9A5D-43E0-BFCE-131E02838073Q26852376-DB79169B-848E-4C0A-9370-0CD875EA23D8Q26865163-8CAFE13A-8637-4147-A8A3-3A365C4779E3Q26991771-67FE9E21-6DE9-4842-A2AE-298C472A7025Q27002209-32A3C27D-9202-43A4-90CC-3CAC5AE87C28Q27022017-59BC3656-9EBE-48E7-A5EB-F85D4F5CB6C4Q27317318-D0750806-90B1-437F-9F0E-25C83D37F43DQ28384618-D145F93D-A5B4-4314-81B2-67E54657292DQ28388552-193A9ACA-DDA6-4A41-9386-26F073549D88Q28388641-3AAE0D00-A533-4056-A84A-12D505DCF5B1Q28397980-975FF0BB-0DB0-41E0-8F0B-BCB5D1EC9800Q28481384-0042E8DB-CEEC-4B4E-98A9-5CC73C966DB9Q28543911-39952168-AE39-48F9-B5A8-54FDD951C833Q28546603-5DADB773-8C31-4C7A-B01F-0FACFE94A9EEQ28817133-BB210F25-A123-4028-934A-F32B793866E1Q28818039-DC30AF4C-4CCC-41E5-B001-526A5A523229Q28829301-2D21D9C1-C4BA-4FDB-BCE2-71E399568A80Q30009919-87804200-CB2A-4A04-A8C0-FFE74429BB5BQ30501687-8EC66DD3-6CE4-49A1-BFBC-C1AA835A9857Q30535357-21D47E34-2747-4C2E-B6EB-92028582A61EQ30541000-51D8B45E-C8E8-4774-B504-9F2951C1F904Q30592302-411E2364-507A-4657-AC3C-4FEF6A37FE9BQ30834488-A71F50A8-8142-4ED5-A82C-B4A102E68150Q31018385-2C23CED5-EA34-4BA8-8F95-2116C388710FQ33619608-E3B4B218-8B98-4D1A-901D-7E502D59592FQ33639580-563FBF92-B91E-406F-8BDE-DC48D972AC1EQ33649839-84B8EA93-81DD-4814-AD94-D01E4968BEACQ33682897-5D357561-DFAD-4EC5-961C-301F15766F2FQ33683206-B3A214AF-C4DD-4C0D-839C-29A4FA60EF39Q33748118-7FB3724A-901E-457E-9571-B945016FEC2EQ33804603-9AA529F9-5042-4AB3-89F3-C568EFF6456AQ33837207-148CA335-CAB6-4285-9651-F704D3C21A37Q33862935-C6F12B35-6B4D-44FE-9AE3-ED246DE88F6AQ33877242-6DB8CFB2-A0B3-4C94-9190-2246AB48722CQ33888896-301091E8-86EC-4891-9FD8-49040900A835Q33915173-29E67EBA-EB39-4FD8-8332-1167C8818D7EQ33961526-49380B63-059E-4CC0-BC98-3BF445076BCDQ33962540-39FED247-E750-4C8B-87F8-C35C9BB7C94F
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Endocytosis of nanomedicines.
@ast
Endocytosis of nanomedicines.
@en
type
label
Endocytosis of nanomedicines.
@ast
Endocytosis of nanomedicines.
@en
prefLabel
Endocytosis of nanomedicines.
@ast
Endocytosis of nanomedicines.
@en
P2860
P1476
Endocytosis of nanomedicines
@en
P2093
Daria Y Alakhova
P2860
P304
P356
10.1016/J.JCONREL.2010.01.036
P407
P577
2010-03-10T00:00:00Z